Ipradine Eye Drops (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Shinshin Pharmaceutical Co., Ltd.
MFDS item code 201403435 · Approved 2014.07.28 · Insurance code 643802351
Relief of allergic conjunctivitis symptoms
This medication is used to relieve symptoms such as itching, redness, and tearing of the eyes caused by allergic conjunctivitis. It helps maintain the patient's eye health and reduce discomfort.
Instill 1 drop twice a day (every 6 to 8 hours). If necessary, treatment may continue for up to 4 months.
This medication should not be used by patients who are allergic to the active ingredient or any of its components. Rarely, this medication may cause neurological symptoms such as headache, dizziness, and taste disturbances. Symptoms such as punctate keratitis, ocular pain, dryness, itching, and redness may occasionally occur, and caution is advised. Symptoms like nasal dryness, rhinitis, dry mouth, contact dermatitis, and fatigue may also rarely appear. After using this medication, the eyes may become overly sensitive, and it has been reported that sometimes weakness, cold symptoms, nausea, pharyngitis, abdominal pain, abnormal liver function, and increased blood pressure occur. Increased tear secretion may also be observed. This medication contains phosphates, so care should be taken as corneal calcification may rarely occur in patients with severe corneal damage. After instilling the drops, vision may be temporarily blurred, so one should wait until vision clears before driving or operating machinery. Patients undergoing long-term steroid treatment should gradually reduce the steroid dose under medical supervision when using this medication. Patients with seasonal allergies are advised to start using this medication before symptoms begin and continue until symptoms cease. If there is no effect, care should be taken not to use it for an extended period. The benzalkonium chloride included in this medication may cause eye irritation or discoloration of contact lenses, so contact lenses should not be worn for at least 15 minutes after administration of this medication. It is advisable to avoid wearing contact lenses when the eyes are red. This medication is intended solely for instillation in the eyes and should not be used by injection or orally. Care should be taken to keep the tip of the container clean and avoid contact with the eyes or hands, and the cap should be closed immediately after use. When using with other eye drops, they should be spaced at least 5 minutes apart, and ointments should be applied last. Keep out of reach of children and store in a cool place away from direct sunlight. Pregnant or nursing women should consult a physician before using this medication and carefully consider the effects on the fetus or infant. The safety and efficacy of this medication have not been established in children younger than 3 years, so its use is not recommended. No special dosage adjustment is needed for elderly patients. If this medication is overdosed, immediate observation and treatment by healthcare professionals are required.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a closed container that blocks light, and the storage temperature should be maintained between 4 and 25 degrees Celsius. This way, the ingredients of the medication remain unchanged and safe for use.
A colorless to slightly yellow opaque liquid in a white plastic dropper bottle
6mL / 1 bottle / case
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Shinshin Pharmaceutical Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.